Regional strategy for increasing access to and utilization of new and underutilized vaccines (2009 -2015)
Significant strides have been made towards implementing essential immunization practices in developing countries in the Region. However, complexities of new vaccines and the obstacles faced in bringing them to vulnerable populations demand continued action. The plan outlines the achievements in the Region with regard to new vaccines and presents objectives and future activities aimed at building upon those achievements.
The recently developed Global Immunization Vision and Strategy (GIVS)  outlines broad strategic direction for introduction and wide-spread use of new and underused vaccines and technologies—all of which require long-term programmatic and financial planning, including setting up special surveillance systems. During this plan period, the World Health Organization (WHO) in the Western Pacific Region will concentrate on activities that include preparation for the introduction of new and underused vaccines, continued provision of evidence-based information to country level decision-makers and sharing of experiences from lessons learned. In line with organization policy, several areas of work and components specifically related to standards development, policy and strategy development is centralized to WHO IVB headquarters. To support the advocacy for new vaccine introduction, WPRO will provide evidence of the value of immunization by maintaining regional intelligence on key indicators and disseminating information to guide strategies. In countries that plan to adopt a new vaccine agenda, the WHO Regional Office for the Western Pacific (WPRO) will collaborate with their governments and other partners to develop mechanisms for monitoring immunization financing and programme sustainability. In addition, areas of work and components related to country activities and to implementation are to be decentralized to WHO country offices.
The plan describes seven strategic areas: knowledge management and strategic dissemination of information; surveillance for diseases targeted by new and underutilized vaccines; economic analysis; advocacy with national, regional and global stakeholder to mobilize both national and external resources; providing support on different programmatic areas related to new vaccine introduction; ensuring immunization safety and promoting vaccine research. Each strategic area is accompanied by a set of planned activities, indicators and targets.
Considering the fast evolving field of new and underutilized vaccines, this strategic plan is envisaged to be a dynamic plan. This is for the guidance of the work in this area, but should not become a reason for 'not doing' something, which is not foreseen at this stage, but may become justified in line with new developments in this field.  Global Immunization Vision and Strategy (GIVS), World Health Organization, Geneva (WHO/IVB/05.05), 2005.